G1 Therapeutics to Present at the 2021 Raymond James Human Health Innovation Conference
June 16 2021 - 7:00AM
G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology
company, today announced that G1’s Chief Executive Officer Jack
Bailey will participate in the 2021 Raymond James Human Health
Innovation Conference. The fireside chat will take place on June
22nd at 9:20 AM EDT. This meeting is being held virtually, and a
live webcast will be accessible on the Events & Presentations
page of http://www.g1therapeutics.com.
About G1 TherapeuticsG1
Therapeutics, Inc. is a commercial-stage biopharmaceutical company
focused on the development and commercialization of next generation
therapies that improve the lives of those affected by cancer,
including the Company’s first commercial product, COSELA™
(trilaciclib). G1 has a deep clinical pipeline and is executing a
tumor-agnostic development plan evaluating COSELA in a variety of
solid tumors, including colorectal, breast, lung, and bladder
cancers. G1 Therapeutics is based in Research Triangle Park, N.C.
For additional information, please
visit www.g1therapeutics.com and follow us on
Twitter @G1Therapeutics.
Contacts:Will RobertsVice President, Investor
Relations & Corporate Communications919-907-1944
wroberts@g1therapeutics.com
G1 Therapeutics (NASDAQ:GTHX)
Historical Stock Chart
From Mar 2024 to Apr 2024
G1 Therapeutics (NASDAQ:GTHX)
Historical Stock Chart
From Apr 2023 to Apr 2024